 |
市場調查報告書
商品編碼
1477268
局部給藥市場，依配方、依給藥途徑、依配銷通路、地理位置Topical Drug Delivery Market, By Formulation, By Route of Administration, By Distribution Channel, By Geography |
||||||
預計2024年局部給藥市值為1,249億美元，預計2031年將達2,299.1億美元，2024年至2031年的年複合成長率（CAGR）為9.1%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2023年 | 2024 年市場規模： | 1,249億美元 |
| 歷史數據： | 2019年至2023年 | 預測期： | 2024年至2031年 |
| 預測 2024 年至 2031 年複合年成長率： | 9.10% | 2031 年價值預測： | 2299.1 億美元 |
局部藥物遞送是指將治療化合物直接施用到作用部位。這種局部藥物傳輸旨在最大限度地提高治療效果，同時最大限度地減少全身副作用。它涉及將凝膠、霜劑、泡沫、薄膜等製劑應用於皮膚或黏膜表面。與全身給藥相比，局部給藥可以以較低的總劑量在目標組織中提供更高的藥物濃度。這提高了功效和安全性。對疼痛管理和皮膚病治療的需求不斷成長是推動人們對局部給藥方式產生興趣的一個主要因素。
市場動態：
易患各種疾病的老年人口不斷增加、皮膚病和眼科疾病患病率上升以及對疼痛管理療法的需求不斷增加，推動了局部給藥市場的發展。然而，由於角質層等生物屏障導致的藥物滲透問題構成了課題。從積極的一面來看，奈米載體、脂質系統和新型聚合物等配方技術的不斷進步正在擴大可能性並改善滲透性。新興經濟體不斷成長的醫療支出也帶來了機會。近年來，局部給藥市場取得了顯著的技術進步。新的創新旨在增強藥物輸送的皮膚滲透性，同時提高治療效果和患者舒適度。一個關鍵趨勢是奈米級輸送系統的發展。奈米顆粒配方可以幫助藥物滲透到皮膚更深層。這克服了治療皮膚病的主要障礙。脂質體、聚合物奈米粒子、樹枝狀聚合物和奈米乳液都在經皮遞送方面顯示出前景。研究人員正在探索最佳化顆粒大小、成分和表面電荷的方法，以最大限度地提高皮膚滲透性。
研究的主要特點：
- 該報告對全球局部給藥市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
- 它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
- 這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
- 它根據以下參數描述了全球局部給藥市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
- 該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 全球局部給藥市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
- 利害關係人可以透過用於分析全球局部給藥市場的各種策略矩陣輕鬆做出決策。
目錄
第1章：研究目標與假設
- 研究目標
- 假設
- 縮寫
第 2 章：市場範圍
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map (COM)
第 3 章：市場動態、法規與趨勢分析
- 市場動態
- 促進要素
- 限制
- 機會
- 影響分析
- 市場走向
- 最近的發展
- 收購和合作場景
- 技術概覽
- 監管場景
- 定價分析
- PEST分析
第 4 章：全球局部給藥市場 - 冠狀病毒 (COVID-19) 大流行的影響
- 整體影響
- 政府舉措
- COVID-19 對市場的影響
第 5 章：2019 - 2031 年全球外用藥物輸送市場（依配方）（十億美元）
- 概述
- 液體配方
- 半固體製劑
- 固體製劑
- 經皮貼劑
第 6 章：2019 - 2031 年全球局部給藥市場（依給藥途徑）（十億美元）
- 概述
- 真皮
- 直腸
- 陰道
- 其他
第 7 章：全球外用藥物輸送市場，依配銷通路，2019 - 2031 年（十億美元）
- 概述
- 醫院藥房
- 零售藥局
- 網路藥局
第 8 章：2019 - 2031 年全球局部給藥市場（依地區）（十億美元）
- 介紹
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 歐洲其他地區
- 亞太地區
- 中國
- 印度
- 日本
- 東協
- 澳洲
- 韓國
- 亞太地區其他地區
- 中東
- 海灣合作理事會
- 以色列
- 中東其他地區
- 非洲
- 北非
- 中非
- 南非
第 9 章：競爭格局
- 公司簡介
- Johnson & Johnson
- Pfizer Inc.
- Novartis International AG
- GSK plc
- Bayer AG
- Merck & Co., Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Eli Lilly and Company
- Galderma Laboratories, LP
- Viatris Inc.
- Sun Pharmaceutical Industries Ltd.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Taro Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Ltd.
- Almirall SA
第 10 章：分析師觀點
- 命運之輪
- 分析師觀點
- 連貫的機會圖
第 11 章：參考文獻與研究方法
- 參考
- 研究方法論
The topical drug delivery market is estimated to be valued at USD 124.90 Bn in 2024 and is expected to reach USD 229.91 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 124.90 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 9.10% | 2031 Value Projection: | US$ 229.91 Bn |
Topical drug delivery refers to the administration of therapeutic compounds directly to the site of action. This localized drug delivery aims to maximize the therapeutic effects while minimizing the systemic side effects. It involves the application of formulations like gels, creams, foams, films, etc. to the skin or mucosal surfaces. Compared to systemic delivery, topical drug administration allows higher drug concentration in the targeted tissue with lower overall doses. This enhances efficacy and safety. The growing demand for pain management and dermatological therapies is a major factor driving interest in topical delivery modalities.
Market Dynamics:
The topical drug delivery market is driven by the growing geriatric population susceptible to various diseases, rising prevalence of dermatological and ophthalmic conditions, and increasing demand for pain management therapies. However, drug permeation issues owing to biological barriers like stratum corneum pose a challenge. On the positive side, ongoing advancements in formulation technologies like nanocarriers, lipid-based systems, and novel polymers are expanding the possibilities and improving permeation. Growing healthcare expenditure in emerging economies also opens up opportunities. The topical drug delivery market has seen significant technological advancements in recent years. New innovations aim to enhance skin permeability for drug delivery while also improving treatment efficacy and patient comfort. One key trend is the development of nano-scale delivery systems. Nanoparticle formulations can help medications penetrate deeper layers of the skin. This overcomes a major barrier for treating dermatological conditions. Liposomes, polymeric nanoparticles, dendrimers, and nano emulsions have all shown promise in transdermal delivery. Researchers are exploring ways to optimize particle size, composition, and surface charge to maximize skin permeation.
Key Features of the Study:
- This report provides an in-depth analysis of the global topical drug delivery market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global topical drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study includes Johnson & Johnson, Pfizer Inc., Novartis International AG, GSK plc, Bayer AG, Merck & Co., Inc., Sanofi, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Eli Lilly and Company, Galderma Laboratories, L.P., Viatris Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Bausch Health Companies Inc., Taro Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., and Almirall S.A.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global topical drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global topical drug delivery market
Market Segmentation
- By Formulation:
- Liquid Formulations
- Semi-Solid Formulations
- Solid Formulations
- Transdermal Patches
- By Route of Administration:
- Dermal
- Rectal
- Vaginal
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Johnson & Johnson
- Pfizer Inc.
- Novartis International AG
- GSK plc
- Bayer AG
- Merck & Co., Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Eli Lilly and Company
- Galderma Laboratories, L.P.
- Viatris Inc.
- Sun Pharmaceutical Industries Ltd.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Taro Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Ltd.
- Almirall S.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Formulation
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnership Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
4. Global Topical Drug Delivery Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 impact on the market
5. Global Topical Drug Delivery Market, By Formulation, 2019 - 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Liquid Formulations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Semi-Solid Formulations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Solid Formulations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Transdermal Patches
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
6. Global Topical Drug Delivery Market, By Route of Administration, 2019 - 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Dermal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Rectal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Vaginal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
7. Global Topical Drug Delivery Market, By Distribution Channel, 2019 - 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
8. Global Topical Drug Delivery Market, By Region, 2019 - 2031, (USD BN)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD BN)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Johnson & Johnson*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Novartis International AG
- GSK plc
- Bayer AG
- Merck & Co., Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Eli Lilly and Company
- Galderma Laboratories, L.P.
- Viatris Inc.
- Sun Pharmaceutical Industries Ltd.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Taro Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Ltd.
- Almirall S.A.
10. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
